Monte Rosa Therapeutics (GLUE) Institutional Ownership $4.92 +0.12 (+2.50%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$4.91 -0.01 (-0.20%) As of 09/2/2025 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monte Rosa Therapeutics (NASDAQ:GLUE)CurrentInstitutional OwnershipPercentage79.96%Number ofInstitutional Buyers(last 12 months)75TotalInstitutional Inflows(last 12 months)$117.69MNumber ofInstitutional Sellers(last 12 months)19TotalInstitutional Outflows(last 12 months)$24.75M Get GLUE Insider Trade Alerts Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GLUE Institutional Buying and Selling by Quarter Monte Rosa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/28/2025 China Universal Asset Management Co. Ltd.32,354$146K0.0%+162.5%0.052% 8/27/2025 Squarepoint Ops LLC178,136$803K0.0%N/A0.288% 8/15/2025 Man Group plc36,391$164K0.0%N/A0.059% 8/15/2025 Lazard Asset Management LLC10,857$48K0.0%+42.9%0.018% 8/15/2025 Bridgeway Capital Management LLC271,400$1.22M0.0%N/A0.439% 8/15/2025 Bank of America Corp DE271,164$1.22M0.0%+941.1%0.439% 8/15/2025 AQR Capital Management LLC1,283,942$5.79M0.0%+459.4%2.079% 8/14/2025 The Manufacturers Life Insurance Company 119,836$540K0.0%+2.2%0.194% 8/14/2025 Squarepoint Ops LLC178,136$803K0.0%N/A0.288% 8/14/2025 Sei Investments Co.16,406$74K0.0%N/A0.027% Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Qube Research & Technologies Ltd203,420$917K0.0%+317.7%0.329% 8/13/2025 Marshall Wace LLP446,080$2.01M0.0%+20.0%0.722% 8/13/2025 Stonepine Capital Management LLC30,000$135K0.1%N/A0.049% 8/13/2025 Invesco Ltd.65,389$295K0.0%+85.0%0.106% 8/12/2025 XTX Topco Ltd54,440$246K0.0%N/A0.088% 8/12/2025 Prudential Financial Inc.12,054$54K0.0%N/A0.020% 8/12/2025 American Century Companies Inc.403,045$1.82M0.0%+301.4%0.653% 8/12/2025 Franklin Resources Inc.84,488$381K0.0%+213.5%0.137% 8/12/2025 Hillsdale Investment Management Inc.60,100$271K0.0%N/A0.097% 8/11/2025 Integrated Quantitative Investments LLC35,400$160K0.0%N/A0.058% 8/8/2025 Intech Investment Management LLC29,870$135K0.0%+35.4%0.049% 8/8/2025 Bailard Inc.22,500$101K0.0%N/A0.037% 8/8/2025 Geode Capital Management LLC1,124,160$5.07M0.0%+12.0%1.828% 8/7/2025 Los Angeles Capital Management LLC19,787$89K0.0%N/A0.032% 7/31/2025 Brighton Jones LLC10,559$48K0.0%N/A0.017% 7/25/2025 CWM LLC28,326$128K0.0%+664.3%0.046% 7/10/2025 Wealth Enhancement Advisory Services LLC20,007$97K0.0%N/A0.033% 7/9/2025 Pallas Capital Advisors LLC13,182$59K0.0%N/A0.021% 5/21/2025 Acadian Asset Management LLC16,385$76K0.0%N/A0.027% 5/16/2025 Goldman Sachs Group Inc.356,112$1.65M0.0%+122.7%0.579% 5/16/2025 Parkwood LLC708,000$3.29M0.3%+119.2%1.151% 5/16/2025 BVF Inc. IL5,660,132$26.26M1.1%+104.7%9.202% 5/16/2025 AQR Capital Management LLC229,536$1.07M0.0%N/A0.373% 5/15/2025 Trexquant Investment LP26,188$122K0.0%N/A0.043% 5/14/2025 AlphaQuest LLC27,251$126K0.0%-71.2%0.044% 5/14/2025 Wellington Management Group LLP187,731$871K0.0%-15.3%0.305% 5/13/2025 American Century Companies Inc.100,406$466K0.0%+30.7%0.163% 5/13/2025 Fox Run Management L.L.C.27,394$127K0.0%N/A0.045% 5/12/2025 Nuveen LLC117,672$546K0.0%N/A0.191% 5/12/2025 Invesco Ltd.35,346$164K0.0%+175.1%0.057% Turn $1K into $50K with This DeFi Gem (Ad)Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.Click here to get all the details5/9/2025 Deutsche Bank AG24,850$115K0.0%-14.5%0.040% 5/9/2025 Charles Schwab Investment Management Inc.361,535$1.68M0.0%-2.4%0.588% 5/7/2025 Corton Capital Inc.29,348$136K0.4%-9.3%0.048% 5/7/2025 TD Asset Management Inc172,078$798K0.0%-21.8%0.280% 5/6/2025 Readystate Asset Management LP287,000$1.33M0.0%N/A0.467% 4/29/2025 Bank of New York Mellon Corp164,145$762K0.0%-3.6%0.267% 4/17/2025 Exchange Traded Concepts LLC18,928$88K0.0%-36.5%0.031% 3/24/2025 Wellington Management Group LLP221,741$1.54M0.0%+2.2%0.361% 2/17/2025 Vestal Point Capital LP425,000$2.95M0.2%-54.3%0.692% 2/17/2025 Squarepoint Ops LLC31,654$220K0.0%N/A0.052% 2/17/2025 Two Sigma Advisers LP26,000$180K0.0%N/A0.042% 2/17/2025 Two Sigma Investments LP278,785$1.94M0.0%+1,965.1%0.454% 2/17/2025 Suvretta Capital Management LLC1,563,798$10.85M0.4%-41.2%2.545% 2/17/2025 Sherbrooke Park Advisers LLC14,476$100K0.0%-27.6%0.024% 2/17/2025 Rafferty Asset Management LLC27,698$192K0.0%N/A0.045% 2/17/2025 ProShare Advisors LLC14,541$101K0.0%N/A0.024% 2/17/2025 Parkwood LLC323,000$2.24M0.2%-24.3%0.526% 2/17/2025 Millennium Management LLC46,370$322K0.0%+51.4%0.075% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,701$172K0.0%+9.2%0.040% 2/17/2025 Focus Partners Wealth11,122$77K0.0%N/A0.018% 2/17/2025 Deutsche Bank AG29,064$202K0.0%+29.6%0.047% 2/17/2025 D. E. Shaw & Co. Inc.70,114$487K0.0%+283.3%0.114% 2/17/2025 Corton Capital Inc.32,366$225K0.1%N/A0.053% 2/17/2025 Cubist Systematic Strategies LLC92,818$644K0.0%N/A0.151% 2/17/2025 BVF Inc. IL2,764,471$19.19M0.7%N/A4.499% 2/17/2025 Bank of America Corp DE63,283$439K0.0%-13.8%0.103% 2/17/2025 BNP Paribas Financial Markets6,231$43K0.0%N/A0.010% 2/14/2025 Jane Street Group LLC14,581$101K0.0%-12.9%0.024% 2/14/2025 Northern Trust Corp376,964$2.62M0.0%+5.1%0.614% 2/14/2025 Virtus ETF Advisers LLC9,126$63K0.0%N/A0.015% 2/14/2025 Price T Rowe Associates Inc. MD7,116,637$49.39M0.0%+7.8%11.583% 2/14/2025 Avoro Capital Advisors LLC4,345,000$30.15M0.4%-25.0%7.072% 2/14/2025 Tower Research Capital LLC TRC5,443$38K0.0%+192.8%0.009% 2/14/2025 Dimensional Fund Advisors LP144,811$1.01M0.0%+4.0%0.236% 2/13/2025 Marshall Wace LLP499,492$3.47M0.0%+187.3%0.813% 2/13/2025 Jump Financial LLC154,842$1.08M0.0%N/A0.252% 2/13/2025 Walleye Capital LLC39,647$275K0.0%N/A0.065% 2/13/2025 Barclays PLC70,741$491K0.0%+29.8%0.115% 2/13/2025 Renaissance Technologies LLC245,700$1.71M0.0%+12.3%0.400% 2/13/2025 Legal & General Group Plc3,597$25K0.0%-78.3%0.006% 2/13/2025 Invesco Ltd.12,847$89K0.0%N/A0.021% 2/13/2025 Wells Fargo & Company MN70,162$487K0.0%+215.9%0.114% 2/12/2025 Geode Capital Management LLC1,036,665$7.20M0.0%-0.8%1.687% 2/12/2025 Franklin Resources Inc.27,510$191K0.0%N/A0.045% 2/12/2025 Wellington Management Group LLP221,741$1.54M0.0%+2.2%0.361% 2/12/2025 Norges Bank445,868$3.09M0.0%N/A0.726% 2/12/2025 JPMorgan Chase & Co.24,094$167K0.0%+29.9%0.039% 2/12/2025 Versant Venture Management LLC5,652,922$39.23M45.2%N/A9.201% 2/11/2025 Vanguard Group Inc.3,156,354$21.91M0.0%+24.5%5.137% 2/11/2025 Sei Investments Co.17,236$120K0.0%N/A0.028% Turn $1K into $50K with This DeFi Gem (Ad)Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.Click here to get all the details2/11/2025 American Century Companies Inc.76,850$533K0.0%+27.3%0.125% 2/7/2025 AlphaQuest LLC94,633$657K0.1%N/A0.154% 2/6/2025 Charles Schwab Investment Management Inc.370,472$2.57M0.0%+6.9%0.603% 2/4/2025 Bank of New York Mellon Corp170,312$1.18M0.0%+2.2%0.277% 1/30/2025 Rhumbline Advisers61,791$429K0.0%+17.8%0.101% 1/24/2025 China Universal Asset Management Co. Ltd.13,027$90K0.0%N/A0.021% 1/17/2025 Janney Montgomery Scott LLC13,315$92K0.0%N/A0.022% 1/17/2025 SG Americas Securities LLC16,742$116K0.0%+60.7%0.027% 1/3/2025 GAMMA Investing LLC5,921$41K0.0%+10,665.5%0.010% 12/26/2024 JPMorgan Chase & Co.18,543$98K0.0%+38.2%0.030% (Data available from 1/1/2016 forward) GLUE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLUE shares? During the previous two years, 86 institutional investors and hedge funds held shares of Monte Rosa Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($49.39M), Versant Venture Management LLC ($39.23M), Avoro Capital Advisors LLC ($30.15M), FMR LLC ($27.04M), BVF Inc. IL ($26.26M), Vanguard Group Inc. ($21.91M), and Suvretta Capital Management LLC ($10.85M).Learn more on Monte Rosa Therapeutics' institutional investors. What percentage of Monte Rosa Therapeutics' stock is owned by institutional investors? 79.96% of Monte Rosa Therapeutics' stock is owned by institutional investors. Learn more on GLUE's institutional investor holdings. Which institutional investors have been buying Monte Rosa Therapeutics' stock? Of the 79 institutional investors that purchased Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($5.66M), Versant Venture Management LLC ($5.65M), AQR Capital Management LLC ($1.28M), Price T Rowe Associates Inc. MD ($671.38K), Vanguard Group Inc. ($669.55K), Norges Bank ($445.87K), and Marshall Wace LLP ($399.99K). How much institutional buying is happening at Monte Rosa Therapeutics? Institutional investors have bought a total of 19,632,147 shares in the last 24 months. This purchase volume represents approximately $117.69M in transactions. Which of Monte Rosa Therapeutics' major shareholders have been selling company stock? Of the 19 institutional investors that sold Monte Rosa Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Avoro Capital Advisors LLC ($1.45M), Suvretta Capital Management LLC ($1.10M), Vestal Point Capital LP ($505K), Sphera Funds Management LTD. ($256.90K), Parkwood LLC ($103.62K), AlphaQuest LLC ($67.38K), and Jane Street Group LLC ($53.17K). How much institutional selling is happening at Monte Rosa Therapeutics? Institutional investors have sold a total of 3,706,944 shares in the last 24 months. This volume of shares sold represents approximately $24.75M in transactions. Related Companies CALT Major Shareholders SION Major Shareholders RCUS Major Shareholders ZYME Major Shareholders GPCR Major Shareholders LENZ Major Shareholders STOK Major Shareholders CRMD Major Shareholders SYRE Major Shareholders MLYS Major Shareholders This page (NASDAQ:GLUE) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLUE Stock Alerts